HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Previous close
$7.41
Day range
$7.14 - $7.55
Year range
$6.54 - $30.60
Market cap
65.14M USD
Avg Volume
130.00K
P/E ratio
0.81
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.71M | -31.15% |
Net income | 32.68M | 181.43% |
Net profit margin | — | — |
Earnings per share | -2.24 | 58.56% |
EBITDA | -26.16M | 20.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.85M | -47.07% |
Total assets | 164.18M | -51.89% |
Total liabilities | 113.72M | -71.64% |
Total equity | 50.46M | — |
Shares outstanding | 8.73M | — |
Price to book | 1.28 | — |
Return on assets | -44.80% | — |
Return on capital | -55.48% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 32.68M | 181.43% |
Cash from operations | 26.91M | 176.37% |
Cash from investing | -34.00K | 45.16% |
Cash from financing | 1.18M | -93.71% |
Net change in cash | 28.06M | 269.67% |
Free cash flow | -22.78M | 2.79% |
About
CEO
Founded
2010
Website
Employees
103
